These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11213528)

  • 1. Possible cellular mechanism accounting for the cell type-specific vulnerability in Huntington's disease.
    Centonze D; Giacomini P; Tolu M; Bernardi G; Calabresi P
    Funct Neurol; 2000; 15(4):253-8. PubMed ID: 11213528
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuronal vulnerability in mouse models of Huntington's disease: membrane channel protein changes.
    Ariano MA; Wagle N; Grissell AE
    J Neurosci Res; 2005 Jun; 80(5):634-45. PubMed ID: 15880743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective neuronal degeneration in Huntington's disease.
    Cowan CM; Raymond LA
    Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of striatal neurons to excitotoxic injury correlates with basal levels of Bcl-2 and the induction of P53 and c-Myc immunoreactivity.
    Liang ZQ; Wang XX; Wang Y; Chuang DM; DiFiglia M; Chase TN; Qin ZH
    Neurobiol Dis; 2005 Nov; 20(2):562-73. PubMed ID: 15922606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striatal modulation of cAMP-response-element-binding protein (CREB) after excitotoxic lesions: implications with neuronal vulnerability in Huntington's disease.
    Giampà C; DeMarch Z; D'Angelo V; Morello M; Martorana A; Sancesario G; Bernardi G; Fusco FR
    Eur J Neurosci; 2006 Jan; 23(1):11-20. PubMed ID: 16420411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of N-methyl-D-aspartate receptor inhibition by melatonin in the rat striatum.
    Escames G; León J; López LC; Acuña-Castroviejo D
    J Neuroendocrinol; 2004 Nov; 16(11):929-35. PubMed ID: 15584934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease.
    Shehadeh J; Fernandes HB; Zeron Mullins MM; Graham RK; Leavitt BR; Hayden MR; Raymond LA
    Neurobiol Dis; 2006 Feb; 21(2):392-403. PubMed ID: 16165367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal gray matter loss in Huntington's disease is leftward biased.
    Mühlau M; Gaser C; Wohlschläger AM; Weindl A; Städtler M; Valet M; Zimmer C; Kassubek J; Peinemann A
    Mov Disord; 2007 Jun; 22(8):1169-73. PubMed ID: 17394246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons.
    Rudinskiy N; Kaneko YA; Beesen AA; Gokce O; Régulier E; Déglon N; Luthi-Carter R
    J Neurochem; 2009 Oct; 111(2):460-72. PubMed ID: 19686238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormalities of striatal projection neurons and N-methyl-D-aspartate receptors in presymptomatic Huntington's disease.
    Albin RL; Young AB; Penney JB; Handelin B; Balfour R; Anderson KD; Markel DS; Tourtellotte WW; Reiner A
    N Engl J Med; 1990 May; 322(18):1293-8. PubMed ID: 1691447
    [No Abstract]   [Full Text] [Related]  

  • 12. Striatal neural grafting improves cortical metabolism in Huntington's disease patients.
    Gaura V; Bachoud-Lévi AC; Ribeiro MJ; Nguyen JP; Frouin V; Baudic S; Brugières P; Mangin JF; Boissé MF; Palfi S; Cesaro P; Samson Y; Hantraye P; Peschanski M; Remy P
    Brain; 2004 Jan; 127(Pt 1):65-72. PubMed ID: 14607797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methyl-D-aspartate (NMDA) receptor function and excitotoxicity in Huntington's disease.
    Fan MM; Raymond LA
    Prog Neurobiol; 2007 Apr; 81(5-6):272-93. PubMed ID: 17188796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopamine level contributes to hydroxyl radical generation and subsequent neurodegeneration in the striatum in 3-nitropropionic acid-induced Huntington's disease in rats.
    Pandey M; Borah A; Varghese M; Barman PK; Mohanakumar KP; Usha R
    Neurochem Int; 2009 Nov; 55(6):431-7. PubMed ID: 19410615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17 beta-Estradiol may affect vulnerability of striatum in a 3-nitropropionic acid-induced experimental model of Huntington's disease in ovariectomized rats.
    Túnez I; Collado JA; Medina FJ; Peña J; Del C Muñoz M; Jimena I; Franco F; Rueda I; Feijóo M; Muntané J; Montilla P
    Neurochem Int; 2006 Apr; 48(5):367-73. PubMed ID: 16420966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
    Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
    Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium channel beta4 subunit: down-regulation and possible involvement in neuritic degeneration in Huntington's disease transgenic mice.
    Oyama F; Miyazaki H; Sakamoto N; Becquet C; Machida Y; Kaneko K; Uchikawa C; Suzuki T; Kurosawa M; Ikeda T; Tamaoka A; Sakurai T; Nukina N
    J Neurochem; 2006 Jul; 98(2):518-29. PubMed ID: 16805843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters.
    Estrada-Sánchez AM; Montiel T; Segovia J; Massieu L
    Neurobiol Dis; 2009 Apr; 34(1):78-86. PubMed ID: 19168136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoid (CB(1)), GABA(A) and GABA(B) receptor subunit changes in the globus pallidus in Huntington's disease.
    Allen KL; Waldvogel HJ; Glass M; Faull RL
    J Chem Neuroanat; 2009 Jul; 37(4):266-81. PubMed ID: 19481011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.